nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Prednisolone—ankylosing spondylitis	0.346	1	CrCtD
Progesterone—NR3C2—Betamethasone—ankylosing spondylitis	0.035	0.115	CbGbCtD
Progesterone—NR3C2—Prednisolone—ankylosing spondylitis	0.0345	0.113	CbGbCtD
Progesterone—PGR—Betamethasone—ankylosing spondylitis	0.0226	0.0741	CbGbCtD
Progesterone—NR3C2—Dexamethasone—ankylosing spondylitis	0.0204	0.0667	CbGbCtD
Progesterone—CYP17A1—Dexamethasone—ankylosing spondylitis	0.019	0.0622	CbGbCtD
Progesterone—NR3C1—Methylprednisolone—ankylosing spondylitis	0.0178	0.0582	CbGbCtD
Progesterone—NR3C1—Triamcinolone—ankylosing spondylitis	0.0135	0.0441	CbGbCtD
Progesterone—PGR—Dexamethasone—ankylosing spondylitis	0.0131	0.0431	CbGbCtD
Progesterone—NR3C1—Betamethasone—ankylosing spondylitis	0.0115	0.0378	CbGbCtD
Progesterone—NR3C1—Prednisolone—ankylosing spondylitis	0.0114	0.0373	CbGbCtD
Progesterone—NR3C1—Prednisone—ankylosing spondylitis	0.0108	0.0352	CbGbCtD
Progesterone—Potassium Canrenoate—Prednisone—ankylosing spondylitis	0.0106	0.0351	CrCrCtD
Progesterone—Potassium Canrenoate—Prednisolone—ankylosing spondylitis	0.0104	0.0343	CrCrCtD
Progesterone—Medrysone—Methylprednisolone—ankylosing spondylitis	0.00982	0.0325	CrCrCtD
Progesterone—Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.00946	0.0313	CrCrCtD
Progesterone—ABCB11—Dexamethasone—ankylosing spondylitis	0.00912	0.0299	CbGbCtD
Progesterone—CYP1B1—Dexamethasone—ankylosing spondylitis	0.00912	0.0299	CbGbCtD
Progesterone—Danazol—Prednisone—ankylosing spondylitis	0.00896	0.0297	CrCrCtD
Progesterone—Medrysone—Prednisolone—ankylosing spondylitis	0.00875	0.029	CrCrCtD
Progesterone—Hydrocortamate—Methylprednisolone—ankylosing spondylitis	0.00854	0.0283	CrCrCtD
Progesterone—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.00828	0.0274	CrCrCtD
Progesterone—Testolactone—Methylprednisolone—ankylosing spondylitis	0.00803	0.0266	CrCrCtD
Progesterone—CYP2A6—Prednisolone—ankylosing spondylitis	0.00795	0.026	CbGbCtD
Progesterone—Testolactone—Dexamethasone—ankylosing spondylitis	0.0079	0.0262	CrCrCtD
Progesterone—Testolactone—Betamethasone—ankylosing spondylitis	0.0079	0.0262	CrCrCtD
Progesterone—Hydrocortamate—Prednisone—ankylosing spondylitis	0.0078	0.0258	CrCrCtD
Progesterone—Testolactone—Triamcinolone—ankylosing spondylitis	0.00772	0.0256	CrCrCtD
Progesterone—Hydrocortamate—Prednisolone—ankylosing spondylitis	0.00761	0.0252	CrCrCtD
Progesterone—Cortisone acetate—Prednisone—ankylosing spondylitis	0.00755	0.025	CrCrCtD
Progesterone—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.00737	0.0244	CrCrCtD
Progesterone—Testolactone—Prednisone—ankylosing spondylitis	0.00733	0.0243	CrCrCtD
Progesterone—Fluoxymesterone—Betamethasone—ankylosing spondylitis	0.00727	0.0241	CrCrCtD
Progesterone—Fluoxymesterone—Dexamethasone—ankylosing spondylitis	0.00727	0.0241	CrCrCtD
Progesterone—Fludrocortisone—Methylprednisolone—ankylosing spondylitis	0.00719	0.0238	CrCrCtD
Progesterone—Testolactone—Prednisolone—ankylosing spondylitis	0.00715	0.0237	CrCrCtD
Progesterone—Fluoxymesterone—Triamcinolone—ankylosing spondylitis	0.0071	0.0235	CrCrCtD
Progesterone—Fludrocortisone—Betamethasone—ankylosing spondylitis	0.00708	0.0234	CrCrCtD
Progesterone—Fludrocortisone—Dexamethasone—ankylosing spondylitis	0.00708	0.0234	CrCrCtD
Progesterone—Fludrocortisone—Triamcinolone—ankylosing spondylitis	0.00692	0.0229	CrCrCtD
Progesterone—NR3C1—Dexamethasone—ankylosing spondylitis	0.00672	0.022	CbGbCtD
Progesterone—Fluoxymesterone—Prednisolone—ankylosing spondylitis	0.00658	0.0218	CrCrCtD
Progesterone—Fludrocortisone—Prednisone—ankylosing spondylitis	0.00656	0.0217	CrCrCtD
Progesterone—Fludrocortisone—Prednisolone—ankylosing spondylitis	0.00641	0.0212	CrCrCtD
Progesterone—Methyltestosterone—Prednisone—ankylosing spondylitis	0.0064	0.0212	CrCrCtD
Progesterone—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.00625	0.0207	CrCrCtD
Progesterone—Prednisolone—Methylprednisolone—ankylosing spondylitis	0.00611	0.0202	CrCrCtD
Progesterone—Prednisolone—Betamethasone—ankylosing spondylitis	0.00601	0.0199	CrCrCtD
Progesterone—Prednisolone—Dexamethasone—ankylosing spondylitis	0.00601	0.0199	CrCrCtD
Progesterone—Prednisolone—Triamcinolone—ankylosing spondylitis	0.00588	0.0195	CrCrCtD
Progesterone—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.00586	0.0194	CrCrCtD
Progesterone—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.00577	0.0191	CrCrCtD
Progesterone—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.00577	0.0191	CrCrCtD
Progesterone—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.00564	0.0187	CrCrCtD
Progesterone—Prednisolone—Prednisone—ankylosing spondylitis	0.00558	0.0185	CrCrCtD
Progesterone—Testosterone—Prednisolone—ankylosing spondylitis	0.00556	0.0184	CrCrCtD
Progesterone—Hydrocortisone—Prednisone—ankylosing spondylitis	0.00535	0.0177	CrCrCtD
Progesterone—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.00522	0.0173	CrCrCtD
Progesterone—ABCC1—Methotrexate—ankylosing spondylitis	0.00521	0.0171	CbGbCtD
Progesterone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.00481	0.0158	CbGbCtD
Progesterone—CYP2A6—Dexamethasone—ankylosing spondylitis	0.00469	0.0154	CbGbCtD
Progesterone—ABCB1—Methylprednisolone—ankylosing spondylitis	0.00413	0.0135	CbGbCtD
Progesterone—CYP1A1—Dexamethasone—ankylosing spondylitis	0.004	0.0131	CbGbCtD
Progesterone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0032	0.0105	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0032	0.0105	CbGbCtD
Progesterone—CYP2C19—Prednisone—ankylosing spondylitis	0.0031	0.0102	CbGbCtD
Progesterone—ABCB1—Betamethasone—ankylosing spondylitis	0.00269	0.00881	CbGbCtD
Progesterone—ABCB1—Prednisolone—ankylosing spondylitis	0.00265	0.00869	CbGbCtD
Progesterone—ABCB1—Prednisone—ankylosing spondylitis	0.0025	0.00821	CbGbCtD
Progesterone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00248	0.00812	CbGbCtD
Progesterone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0024	0.00787	CbGbCtD
Progesterone—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00231	0.00757	CbGbCtD
Progesterone—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00194	0.00635	CbGbCtD
Progesterone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00188	0.00615	CbGbCtD
Progesterone—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00161	0.00528	CbGbCtD
Progesterone—CYP3A4—Betamethasone—ankylosing spondylitis	0.00161	0.00528	CbGbCtD
Progesterone—CYP3A4—Prednisolone—ankylosing spondylitis	0.00159	0.00521	CbGbCtD
Progesterone—ABCB1—Dexamethasone—ankylosing spondylitis	0.00156	0.00512	CbGbCtD
Progesterone—CYP3A4—Prednisone—ankylosing spondylitis	0.0015	0.00492	CbGbCtD
Progesterone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00147	0.00483	CbGbCtD
Progesterone—ABCB1—Methotrexate—ankylosing spondylitis	0.00126	0.00412	CbGbCtD
Progesterone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.000937	0.00307	CbGbCtD
Progesterone—Syncope—Betamethasone—ankylosing spondylitis	4.61e-05	0.000991	CcSEcCtD
Progesterone—Infection—Triamcinolone—ankylosing spondylitis	4.6e-05	0.000988	CcSEcCtD
Progesterone—Infection—Methylprednisolone—ankylosing spondylitis	4.59e-05	0.000985	CcSEcCtD
Progesterone—Shock—Triamcinolone—ankylosing spondylitis	4.55e-05	0.000978	CcSEcCtD
Progesterone—Insomnia—Prednisolone—ankylosing spondylitis	4.55e-05	0.000978	CcSEcCtD
Progesterone—Alopecia—Prednisone—ankylosing spondylitis	4.55e-05	0.000977	CcSEcCtD
Progesterone—Shock—Methylprednisolone—ankylosing spondylitis	4.54e-05	0.000976	CcSEcCtD
Progesterone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	4.53e-05	0.000974	CcSEcCtD
Progesterone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	4.53e-05	0.000973	CcSEcCtD
Progesterone—Loss of consciousness—Betamethasone—ankylosing spondylitis	4.52e-05	0.000971	CcSEcCtD
Progesterone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	4.52e-05	0.000971	CcSEcCtD
Progesterone—Paraesthesia—Prednisolone—ankylosing spondylitis	4.52e-05	0.000971	CcSEcCtD
Progesterone—Tachycardia—Triamcinolone—ankylosing spondylitis	4.52e-05	0.00097	CcSEcCtD
Progesterone—Mental disorder—Prednisone—ankylosing spondylitis	4.51e-05	0.000969	CcSEcCtD
Progesterone—Tachycardia—Methylprednisolone—ankylosing spondylitis	4.51e-05	0.000968	CcSEcCtD
Progesterone—Skin disorder—Methylprednisolone—ankylosing spondylitis	4.48e-05	0.000963	CcSEcCtD
Progesterone—Erythema—Prednisone—ankylosing spondylitis	4.48e-05	0.000963	CcSEcCtD
Progesterone—Malnutrition—Prednisone—ankylosing spondylitis	4.48e-05	0.000963	CcSEcCtD
Progesterone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	4.47e-05	0.000961	CcSEcCtD
Progesterone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	4.46e-05	0.000959	CcSEcCtD
Progesterone—Convulsion—Betamethasone—ankylosing spondylitis	4.46e-05	0.000958	CcSEcCtD
Progesterone—Convulsion—Dexamethasone—ankylosing spondylitis	4.46e-05	0.000958	CcSEcCtD
Progesterone—Hypertension—Dexamethasone—ankylosing spondylitis	4.44e-05	0.000954	CcSEcCtD
Progesterone—Hypertension—Betamethasone—ankylosing spondylitis	4.44e-05	0.000954	CcSEcCtD
Progesterone—Myalgia—Dexamethasone—ankylosing spondylitis	4.38e-05	0.000941	CcSEcCtD
Progesterone—Myalgia—Betamethasone—ankylosing spondylitis	4.38e-05	0.000941	CcSEcCtD
Progesterone—Anxiety—Dexamethasone—ankylosing spondylitis	4.36e-05	0.000938	CcSEcCtD
Progesterone—Anxiety—Betamethasone—ankylosing spondylitis	4.36e-05	0.000938	CcSEcCtD
Progesterone—Discomfort—Betamethasone—ankylosing spondylitis	4.33e-05	0.00093	CcSEcCtD
Progesterone—Discomfort—Dexamethasone—ankylosing spondylitis	4.33e-05	0.00093	CcSEcCtD
Progesterone—Haemoglobin—Methotrexate—ankylosing spondylitis	4.32e-05	0.000929	CcSEcCtD
Progesterone—Hypotension—Methylprednisolone—ankylosing spondylitis	4.31e-05	0.000927	CcSEcCtD
Progesterone—Pain—Prednisolone—ankylosing spondylitis	4.3e-05	0.000924	CcSEcCtD
Progesterone—Haemorrhage—Methotrexate—ankylosing spondylitis	4.3e-05	0.000924	CcSEcCtD
Progesterone—Hepatitis—Methotrexate—ankylosing spondylitis	4.3e-05	0.000924	CcSEcCtD
Progesterone—Pharyngitis—Methotrexate—ankylosing spondylitis	4.27e-05	0.000917	CcSEcCtD
Progesterone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	4.25e-05	0.000913	CcSEcCtD
Progesterone—Vision blurred—Prednisone—ankylosing spondylitis	4.22e-05	0.000907	CcSEcCtD
Progesterone—Urethral disorder—Methotrexate—ankylosing spondylitis	4.22e-05	0.000906	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	4.22e-05	0.000906	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	4.21e-05	0.000904	CcSEcCtD
Progesterone—Oedema—Dexamethasone—ankylosing spondylitis	4.2e-05	0.000902	CcSEcCtD
Progesterone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	4.2e-05	0.000902	CcSEcCtD
Progesterone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	4.2e-05	0.000902	CcSEcCtD
Progesterone—Oedema—Betamethasone—ankylosing spondylitis	4.2e-05	0.000902	CcSEcCtD
Progesterone—Insomnia—Triamcinolone—ankylosing spondylitis	4.18e-05	0.000899	CcSEcCtD
Progesterone—Insomnia—Methylprednisolone—ankylosing spondylitis	4.18e-05	0.000897	CcSEcCtD
Progesterone—Infection—Dexamethasone—ankylosing spondylitis	4.17e-05	0.000896	CcSEcCtD
Progesterone—Infection—Betamethasone—ankylosing spondylitis	4.17e-05	0.000896	CcSEcCtD
Progesterone—Ill-defined disorder—Prednisone—ankylosing spondylitis	4.16e-05	0.000893	CcSEcCtD
Progesterone—Paraesthesia—Triamcinolone—ankylosing spondylitis	4.15e-05	0.000893	CcSEcCtD
Progesterone—Feeling abnormal—Prednisolone—ankylosing spondylitis	4.15e-05	0.000891	CcSEcCtD
Progesterone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	4.15e-05	0.000891	CcSEcCtD
Progesterone—Visual impairment—Methotrexate—ankylosing spondylitis	4.14e-05	0.000891	CcSEcCtD
Progesterone—Anaemia—Prednisone—ankylosing spondylitis	4.14e-05	0.00089	CcSEcCtD
Progesterone—Shock—Betamethasone—ankylosing spondylitis	4.13e-05	0.000887	CcSEcCtD
Progesterone—Shock—Dexamethasone—ankylosing spondylitis	4.13e-05	0.000887	CcSEcCtD
Progesterone—Dyspnoea—Triamcinolone—ankylosing spondylitis	4.13e-05	0.000886	CcSEcCtD
Progesterone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	4.12e-05	0.000885	CcSEcCtD
Progesterone—Nervous system disorder—Betamethasone—ankylosing spondylitis	4.12e-05	0.000885	CcSEcCtD
Progesterone—Tachycardia—Dexamethasone—ankylosing spondylitis	4.1e-05	0.00088	CcSEcCtD
Progesterone—Tachycardia—Betamethasone—ankylosing spondylitis	4.1e-05	0.00088	CcSEcCtD
Progesterone—Angioedema—Prednisone—ankylosing spondylitis	4.09e-05	0.00088	CcSEcCtD
Progesterone—Dyspepsia—Triamcinolone—ankylosing spondylitis	4.07e-05	0.000875	CcSEcCtD
Progesterone—Erythema multiforme—Methotrexate—ankylosing spondylitis	4.07e-05	0.000874	CcSEcCtD
Progesterone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	4.06e-05	0.000873	CcSEcCtD
Progesterone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	4.06e-05	0.000872	CcSEcCtD
Progesterone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	4.06e-05	0.000872	CcSEcCtD
Progesterone—Malaise—Prednisone—ankylosing spondylitis	4.04e-05	0.000868	CcSEcCtD
Progesterone—Vertigo—Prednisone—ankylosing spondylitis	4.02e-05	0.000865	CcSEcCtD
Progesterone—Eye disorder—Methotrexate—ankylosing spondylitis	4.02e-05	0.000864	CcSEcCtD
Progesterone—Syncope—Prednisone—ankylosing spondylitis	4.02e-05	0.000863	CcSEcCtD
Progesterone—Tinnitus—Methotrexate—ankylosing spondylitis	4.01e-05	0.000862	CcSEcCtD
Progesterone—Anorexia—Dexamethasone—ankylosing spondylitis	4e-05	0.00086	CcSEcCtD
Progesterone—Anorexia—Betamethasone—ankylosing spondylitis	4e-05	0.00086	CcSEcCtD
Progesterone—Urticaria—Prednisolone—ankylosing spondylitis	4e-05	0.000859	CcSEcCtD
Progesterone—Cardiac disorder—Methotrexate—ankylosing spondylitis	3.99e-05	0.000858	CcSEcCtD
Progesterone—Fatigue—Triamcinolone—ankylosing spondylitis	3.99e-05	0.000857	CcSEcCtD
Progesterone—Fatigue—Methylprednisolone—ankylosing spondylitis	3.98e-05	0.000855	CcSEcCtD
Progesterone—Pain—Triamcinolone—ankylosing spondylitis	3.96e-05	0.00085	CcSEcCtD
Progesterone—Loss of consciousness—Prednisone—ankylosing spondylitis	3.94e-05	0.000846	CcSEcCtD
Progesterone—Hypotension—Betamethasone—ankylosing spondylitis	3.92e-05	0.000843	CcSEcCtD
Progesterone—Hypotension—Dexamethasone—ankylosing spondylitis	3.92e-05	0.000843	CcSEcCtD
Progesterone—Angiopathy—Methotrexate—ankylosing spondylitis	3.9e-05	0.000838	CcSEcCtD
Progesterone—Immune system disorder—Methotrexate—ankylosing spondylitis	3.88e-05	0.000835	CcSEcCtD
Progesterone—Convulsion—Prednisone—ankylosing spondylitis	3.88e-05	0.000834	CcSEcCtD
Progesterone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	3.88e-05	0.000833	CcSEcCtD
Progesterone—Hypertension—Prednisone—ankylosing spondylitis	3.87e-05	0.000831	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	3.82e-05	0.000822	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	3.82e-05	0.000822	CcSEcCtD
Progesterone—Arthralgia—Prednisone—ankylosing spondylitis	3.81e-05	0.000819	CcSEcCtD
Progesterone—Myalgia—Prednisone—ankylosing spondylitis	3.81e-05	0.000819	CcSEcCtD
Progesterone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	3.81e-05	0.000819	CcSEcCtD
Progesterone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	3.8e-05	0.000817	CcSEcCtD
Progesterone—Anxiety—Prednisone—ankylosing spondylitis	3.8e-05	0.000817	CcSEcCtD
Progesterone—Alopecia—Methotrexate—ankylosing spondylitis	3.8e-05	0.000817	CcSEcCtD
Progesterone—Insomnia—Betamethasone—ankylosing spondylitis	3.8e-05	0.000816	CcSEcCtD
Progesterone—Insomnia—Dexamethasone—ankylosing spondylitis	3.8e-05	0.000816	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	3.79e-05	0.000814	CcSEcCtD
Progesterone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	3.78e-05	0.000811	CcSEcCtD
Progesterone—Paraesthesia—Betamethasone—ankylosing spondylitis	3.77e-05	0.00081	CcSEcCtD
Progesterone—Paraesthesia—Dexamethasone—ankylosing spondylitis	3.77e-05	0.00081	CcSEcCtD
Progesterone—Discomfort—Prednisone—ankylosing spondylitis	3.77e-05	0.00081	CcSEcCtD
Progesterone—Mental disorder—Methotrexate—ankylosing spondylitis	3.77e-05	0.00081	CcSEcCtD
Progesterone—Erythema—Methotrexate—ankylosing spondylitis	3.74e-05	0.000804	CcSEcCtD
Progesterone—Malnutrition—Methotrexate—ankylosing spondylitis	3.74e-05	0.000804	CcSEcCtD
Progesterone—Hypersensitivity—Prednisolone—ankylosing spondylitis	3.71e-05	0.000796	CcSEcCtD
Progesterone—Dyspepsia—Dexamethasone—ankylosing spondylitis	3.7e-05	0.000794	CcSEcCtD
Progesterone—Dyspepsia—Betamethasone—ankylosing spondylitis	3.7e-05	0.000794	CcSEcCtD
Progesterone—Urticaria—Triamcinolone—ankylosing spondylitis	3.68e-05	0.00079	CcSEcCtD
Progesterone—Urticaria—Methylprednisolone—ankylosing spondylitis	3.67e-05	0.000788	CcSEcCtD
Progesterone—Body temperature increased—Triamcinolone—ankylosing spondylitis	3.66e-05	0.000786	CcSEcCtD
Progesterone—Oedema—Prednisone—ankylosing spondylitis	3.66e-05	0.000786	CcSEcCtD
Progesterone—Anaphylactic shock—Prednisone—ankylosing spondylitis	3.66e-05	0.000786	CcSEcCtD
Progesterone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	3.65e-05	0.000784	CcSEcCtD
Progesterone—Decreased appetite—Dexamethasone—ankylosing spondylitis	3.65e-05	0.000784	CcSEcCtD
Progesterone—Decreased appetite—Betamethasone—ankylosing spondylitis	3.65e-05	0.000784	CcSEcCtD
Progesterone—Infection—Prednisone—ankylosing spondylitis	3.63e-05	0.00078	CcSEcCtD
Progesterone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	3.62e-05	0.000779	CcSEcCtD
Progesterone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	3.62e-05	0.000779	CcSEcCtD
Progesterone—Back pain—Methotrexate—ankylosing spondylitis	3.62e-05	0.000778	CcSEcCtD
Progesterone—Fatigue—Betamethasone—ankylosing spondylitis	3.62e-05	0.000778	CcSEcCtD
Progesterone—Fatigue—Dexamethasone—ankylosing spondylitis	3.62e-05	0.000778	CcSEcCtD
Progesterone—Shock—Prednisone—ankylosing spondylitis	3.6e-05	0.000773	CcSEcCtD
Progesterone—Pain—Dexamethasone—ankylosing spondylitis	3.59e-05	0.000771	CcSEcCtD
Progesterone—Pain—Betamethasone—ankylosing spondylitis	3.59e-05	0.000771	CcSEcCtD
Progesterone—Nervous system disorder—Prednisone—ankylosing spondylitis	3.59e-05	0.00077	CcSEcCtD
Progesterone—Tachycardia—Prednisone—ankylosing spondylitis	3.57e-05	0.000767	CcSEcCtD
Progesterone—Skin disorder—Prednisone—ankylosing spondylitis	3.55e-05	0.000763	CcSEcCtD
Progesterone—Hyperhidrosis—Prednisone—ankylosing spondylitis	3.53e-05	0.000759	CcSEcCtD
Progesterone—Vision blurred—Methotrexate—ankylosing spondylitis	3.53e-05	0.000758	CcSEcCtD
Progesterone—Anorexia—Prednisone—ankylosing spondylitis	3.49e-05	0.000749	CcSEcCtD
Progesterone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	3.47e-05	0.000746	CcSEcCtD
Progesterone—Anaemia—Methotrexate—ankylosing spondylitis	3.46e-05	0.000743	CcSEcCtD
Progesterone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	3.46e-05	0.000743	CcSEcCtD
Progesterone—Feeling abnormal—Betamethasone—ankylosing spondylitis	3.46e-05	0.000743	CcSEcCtD
Progesterone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	3.43e-05	0.000738	CcSEcCtD
Progesterone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	3.43e-05	0.000738	CcSEcCtD
Progesterone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	3.41e-05	0.000732	CcSEcCtD
Progesterone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	3.4e-05	0.000731	CcSEcCtD
Progesterone—Malaise—Methotrexate—ankylosing spondylitis	3.38e-05	0.000725	CcSEcCtD
Progesterone—Vertigo—Methotrexate—ankylosing spondylitis	3.36e-05	0.000723	CcSEcCtD
Progesterone—Urticaria—Betamethasone—ankylosing spondylitis	3.34e-05	0.000717	CcSEcCtD
Progesterone—Urticaria—Dexamethasone—ankylosing spondylitis	3.34e-05	0.000717	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	3.33e-05	0.000716	CcSEcCtD
Progesterone—Dizziness—Prednisolone—ankylosing spondylitis	3.33e-05	0.000715	CcSEcCtD
Progesterone—Asthenia—Triamcinolone—ankylosing spondylitis	3.32e-05	0.000713	CcSEcCtD
Progesterone—Abdominal pain—Betamethasone—ankylosing spondylitis	3.32e-05	0.000713	CcSEcCtD
Progesterone—Abdominal pain—Dexamethasone—ankylosing spondylitis	3.32e-05	0.000713	CcSEcCtD
Progesterone—Body temperature increased—Dexamethasone—ankylosing spondylitis	3.32e-05	0.000713	CcSEcCtD
Progesterone—Body temperature increased—Betamethasone—ankylosing spondylitis	3.32e-05	0.000713	CcSEcCtD
Progesterone—Asthenia—Methylprednisolone—ankylosing spondylitis	3.31e-05	0.000712	CcSEcCtD
Progesterone—Insomnia—Prednisone—ankylosing spondylitis	3.31e-05	0.000711	CcSEcCtD
Progesterone—Paraesthesia—Prednisone—ankylosing spondylitis	3.28e-05	0.000705	CcSEcCtD
Progesterone—Pruritus—Triamcinolone—ankylosing spondylitis	3.27e-05	0.000703	CcSEcCtD
Progesterone—Cough—Methotrexate—ankylosing spondylitis	3.27e-05	0.000702	CcSEcCtD
Progesterone—Pruritus—Methylprednisolone—ankylosing spondylitis	3.27e-05	0.000702	CcSEcCtD
Progesterone—Convulsion—Methotrexate—ankylosing spondylitis	3.24e-05	0.000697	CcSEcCtD
Progesterone—Dyspepsia—Prednisone—ankylosing spondylitis	3.22e-05	0.000691	CcSEcCtD
Progesterone—Arthralgia—Methotrexate—ankylosing spondylitis	3.19e-05	0.000685	CcSEcCtD
Progesterone—Chest pain—Methotrexate—ankylosing spondylitis	3.19e-05	0.000685	CcSEcCtD
Progesterone—Myalgia—Methotrexate—ankylosing spondylitis	3.19e-05	0.000685	CcSEcCtD
Progesterone—Decreased appetite—Prednisone—ankylosing spondylitis	3.18e-05	0.000683	CcSEcCtD
Progesterone—Rash—Prednisolone—ankylosing spondylitis	3.17e-05	0.000682	CcSEcCtD
Progesterone—Dermatitis—Prednisolone—ankylosing spondylitis	3.17e-05	0.000681	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	3.17e-05	0.00068	CcSEcCtD
Progesterone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	3.16e-05	0.000679	CcSEcCtD
Progesterone—Fatigue—Prednisone—ankylosing spondylitis	3.15e-05	0.000677	CcSEcCtD
Progesterone—Headache—Prednisolone—ankylosing spondylitis	3.15e-05	0.000677	CcSEcCtD
Progesterone—Discomfort—Methotrexate—ankylosing spondylitis	3.15e-05	0.000677	CcSEcCtD
Progesterone—Constipation—Prednisone—ankylosing spondylitis	3.13e-05	0.000672	CcSEcCtD
Progesterone—Confusional state—Methotrexate—ankylosing spondylitis	3.08e-05	0.000662	CcSEcCtD
Progesterone—Dizziness—Triamcinolone—ankylosing spondylitis	3.06e-05	0.000657	CcSEcCtD
Progesterone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	3.06e-05	0.000657	CcSEcCtD
Progesterone—Dizziness—Methylprednisolone—ankylosing spondylitis	3.05e-05	0.000656	CcSEcCtD
Progesterone—Infection—Methotrexate—ankylosing spondylitis	3.04e-05	0.000652	CcSEcCtD
Progesterone—Feeling abnormal—Prednisone—ankylosing spondylitis	3.01e-05	0.000647	CcSEcCtD
Progesterone—Asthenia—Dexamethasone—ankylosing spondylitis	3.01e-05	0.000647	CcSEcCtD
Progesterone—Asthenia—Betamethasone—ankylosing spondylitis	3.01e-05	0.000647	CcSEcCtD
Progesterone—Nervous system disorder—Methotrexate—ankylosing spondylitis	3e-05	0.000644	CcSEcCtD
Progesterone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	2.99e-05	0.000642	CcSEcCtD
Progesterone—Nausea—Prednisolone—ankylosing spondylitis	2.99e-05	0.000642	CcSEcCtD
Progesterone—Pruritus—Dexamethasone—ankylosing spondylitis	2.97e-05	0.000638	CcSEcCtD
Progesterone—Pruritus—Betamethasone—ankylosing spondylitis	2.97e-05	0.000638	CcSEcCtD
Progesterone—Skin disorder—Methotrexate—ankylosing spondylitis	2.97e-05	0.000638	CcSEcCtD
Progesterone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	2.95e-05	0.000635	CcSEcCtD
Progesterone—Vomiting—Triamcinolone—ankylosing spondylitis	2.94e-05	0.000632	CcSEcCtD
Progesterone—Vomiting—Methylprednisolone—ankylosing spondylitis	2.94e-05	0.000631	CcSEcCtD
Progesterone—Rash—Triamcinolone—ankylosing spondylitis	2.92e-05	0.000627	CcSEcCtD
Progesterone—Dermatitis—Triamcinolone—ankylosing spondylitis	2.91e-05	0.000626	CcSEcCtD
Progesterone—Anorexia—Methotrexate—ankylosing spondylitis	2.91e-05	0.000626	CcSEcCtD
Progesterone—Rash—Methylprednisolone—ankylosing spondylitis	2.91e-05	0.000625	CcSEcCtD
Progesterone—Dermatitis—Methylprednisolone—ankylosing spondylitis	2.91e-05	0.000625	CcSEcCtD
Progesterone—Urticaria—Prednisone—ankylosing spondylitis	2.9e-05	0.000624	CcSEcCtD
Progesterone—Headache—Triamcinolone—ankylosing spondylitis	2.9e-05	0.000623	CcSEcCtD
Progesterone—Headache—Methylprednisolone—ankylosing spondylitis	2.89e-05	0.000621	CcSEcCtD
Progesterone—Abdominal pain—Prednisone—ankylosing spondylitis	2.89e-05	0.000621	CcSEcCtD
Progesterone—Body temperature increased—Prednisone—ankylosing spondylitis	2.89e-05	0.000621	CcSEcCtD
Progesterone—Diarrhoea—Dexamethasone—ankylosing spondylitis	2.87e-05	0.000617	CcSEcCtD
Progesterone—Diarrhoea—Betamethasone—ankylosing spondylitis	2.87e-05	0.000617	CcSEcCtD
Progesterone—Hypotension—Methotrexate—ankylosing spondylitis	2.86e-05	0.000613	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	2.78e-05	0.000598	CcSEcCtD
Progesterone—Dizziness—Betamethasone—ankylosing spondylitis	2.78e-05	0.000596	CcSEcCtD
Progesterone—Dizziness—Dexamethasone—ankylosing spondylitis	2.78e-05	0.000596	CcSEcCtD
Progesterone—Insomnia—Methotrexate—ankylosing spondylitis	2.76e-05	0.000594	CcSEcCtD
Progesterone—Nausea—Triamcinolone—ankylosing spondylitis	2.75e-05	0.000591	CcSEcCtD
Progesterone—Paraesthesia—Methotrexate—ankylosing spondylitis	2.74e-05	0.00059	CcSEcCtD
Progesterone—Nausea—Methylprednisolone—ankylosing spondylitis	2.74e-05	0.000589	CcSEcCtD
Progesterone—Dyspnoea—Methotrexate—ankylosing spondylitis	2.72e-05	0.000585	CcSEcCtD
Progesterone—Somnolence—Methotrexate—ankylosing spondylitis	2.72e-05	0.000584	CcSEcCtD
Progesterone—Hypersensitivity—Prednisone—ankylosing spondylitis	2.69e-05	0.000579	CcSEcCtD
Progesterone—Dyspepsia—Methotrexate—ankylosing spondylitis	2.69e-05	0.000578	CcSEcCtD
Progesterone—Vomiting—Dexamethasone—ankylosing spondylitis	2.67e-05	0.000574	CcSEcCtD
Progesterone—Vomiting—Betamethasone—ankylosing spondylitis	2.67e-05	0.000574	CcSEcCtD
Progesterone—Decreased appetite—Methotrexate—ankylosing spondylitis	2.66e-05	0.000571	CcSEcCtD
Progesterone—Rash—Betamethasone—ankylosing spondylitis	2.65e-05	0.000569	CcSEcCtD
Progesterone—Rash—Dexamethasone—ankylosing spondylitis	2.65e-05	0.000569	CcSEcCtD
Progesterone—Dermatitis—Dexamethasone—ankylosing spondylitis	2.64e-05	0.000568	CcSEcCtD
Progesterone—Dermatitis—Betamethasone—ankylosing spondylitis	2.64e-05	0.000568	CcSEcCtD
Progesterone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	2.64e-05	0.000567	CcSEcCtD
Progesterone—Fatigue—Methotrexate—ankylosing spondylitis	2.63e-05	0.000566	CcSEcCtD
Progesterone—Headache—Betamethasone—ankylosing spondylitis	2.63e-05	0.000565	CcSEcCtD
Progesterone—Headache—Dexamethasone—ankylosing spondylitis	2.63e-05	0.000565	CcSEcCtD
Progesterone—Asthenia—Prednisone—ankylosing spondylitis	2.62e-05	0.000564	CcSEcCtD
Progesterone—Pain—Methotrexate—ankylosing spondylitis	2.61e-05	0.000561	CcSEcCtD
Progesterone—Pruritus—Prednisone—ankylosing spondylitis	2.59e-05	0.000556	CcSEcCtD
Progesterone—Feeling abnormal—Methotrexate—ankylosing spondylitis	2.52e-05	0.000541	CcSEcCtD
Progesterone—Diarrhoea—Prednisone—ankylosing spondylitis	2.5e-05	0.000537	CcSEcCtD
Progesterone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	2.5e-05	0.000537	CcSEcCtD
Progesterone—Nausea—Dexamethasone—ankylosing spondylitis	2.49e-05	0.000536	CcSEcCtD
Progesterone—Nausea—Betamethasone—ankylosing spondylitis	2.49e-05	0.000536	CcSEcCtD
Progesterone—Urticaria—Methotrexate—ankylosing spondylitis	2.43e-05	0.000522	CcSEcCtD
Progesterone—Dizziness—Prednisone—ankylosing spondylitis	2.42e-05	0.000519	CcSEcCtD
Progesterone—Body temperature increased—Methotrexate—ankylosing spondylitis	2.42e-05	0.000519	CcSEcCtD
Progesterone—Abdominal pain—Methotrexate—ankylosing spondylitis	2.42e-05	0.000519	CcSEcCtD
Progesterone—Vomiting—Prednisone—ankylosing spondylitis	2.32e-05	0.000499	CcSEcCtD
Progesterone—Rash—Prednisone—ankylosing spondylitis	2.31e-05	0.000495	CcSEcCtD
Progesterone—Dermatitis—Prednisone—ankylosing spondylitis	2.3e-05	0.000495	CcSEcCtD
Progesterone—Headache—Prednisone—ankylosing spondylitis	2.29e-05	0.000492	CcSEcCtD
Progesterone—Hypersensitivity—Methotrexate—ankylosing spondylitis	2.25e-05	0.000484	CcSEcCtD
Progesterone—Asthenia—Methotrexate—ankylosing spondylitis	2.19e-05	0.000471	CcSEcCtD
Progesterone—Nausea—Prednisone—ankylosing spondylitis	2.17e-05	0.000467	CcSEcCtD
Progesterone—Pruritus—Methotrexate—ankylosing spondylitis	2.16e-05	0.000464	CcSEcCtD
Progesterone—Diarrhoea—Methotrexate—ankylosing spondylitis	2.09e-05	0.000449	CcSEcCtD
Progesterone—Dizziness—Methotrexate—ankylosing spondylitis	2.02e-05	0.000434	CcSEcCtD
Progesterone—Vomiting—Methotrexate—ankylosing spondylitis	1.94e-05	0.000417	CcSEcCtD
Progesterone—Rash—Methotrexate—ankylosing spondylitis	1.93e-05	0.000414	CcSEcCtD
Progesterone—Dermatitis—Methotrexate—ankylosing spondylitis	1.92e-05	0.000414	CcSEcCtD
Progesterone—Headache—Methotrexate—ankylosing spondylitis	1.91e-05	0.000411	CcSEcCtD
Progesterone—Nausea—Methotrexate—ankylosing spondylitis	1.81e-05	0.00039	CcSEcCtD
